about
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.Viral entry pathways: the example of common cold virusesRole of capsid proteins in parvoviruses infectionParvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosisMouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 ActivationLearning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the NucleusOncolytic parvoviruses: from basic virology to clinical applicationsGenomic sequence of Spodoptera frugiperda Ascovirus 1a, an enveloped, double-stranded DNA insect virus that manipulates apoptosis for viral reproductionEarly steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking.Identification and nearly full-length genome characterization of novel porcine bocavirusesBinding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection.Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry.Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains.VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice.Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton.Detecting small changes and additional peptides in the canine parvovirus capsid structurePurified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host rangesAAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.Enhancing gene delivery of adeno-associated viruses by cell-permeable peptidesPathways of cell infection by parvoviruses and adeno-associated virusesIntracellular trafficking of adeno-associated viral vectors.Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses.Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.Characterization of the early steps of human parvovirus B19 infection.Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine.Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleusSurface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activityVisualization of the externalized VP2 N termini of infectious human parvovirus B19.Heparin binding induces conformational changes in Adeno-associated virus serotype 2.Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus.Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assemblyA conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N terminiCytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells
P2860
Q24533013-F2659FD6-B995-4645-B8DD-0286E06F2FBBQ26750146-6960F4A2-18F3-474A-9282-6588419B55EEQ26799552-4FBBF2D0-2503-4BFD-BDAC-6C8CEAAB4E2EQ27332338-68C79DFD-37EF-48C4-A77D-A8C50C01A476Q27486170-80D168DA-3350-4E40-9541-1312437EF6A1Q27488284-605791BA-DDD9-415E-BF40-9DD81F92A2ECQ28081685-C3DA3271-5485-4E44-B62B-5E010D83D0EBQ28766529-E2C13E93-A2E9-4B34-9E78-4D086D0A6DF2Q30490592-31400CB4-5ACA-407E-917B-FA5252E7A015Q33737733-2ED63CB9-29AD-44AF-858A-AA977C03E493Q33826804-24674ADB-21AD-43C2-9438-D2FFB160E5E7Q34144721-533D7A03-2151-4E07-A93A-B90363A695D2Q34150166-8EDAD64A-9A1B-4D6C-9107-8574839A2118Q34233106-A3D48936-3F50-4A71-8BB7-B15C55C84DD2Q34512255-0A781EF7-244A-4725-B15C-70915B77B293Q34808356-4ADB9279-762C-44BF-8EE3-20F6E133726DQ35024094-39EC242D-4292-49DF-973A-6B5E25E02A8AQ35027496-4C22F70B-C9F5-4530-904A-9B3B3B0E125CQ35194907-21558756-6AD4-45D8-84BA-A81478910940Q35803571-31755C74-2B45-4EA4-9EEE-ECB803124848Q36097743-F05610C6-12A5-4CE8-975B-A29947CA3A44Q37336824-639E1DD6-B023-4798-8F01-0B921F66FF85Q37909045-5686A774-B636-44CB-8B52-14B1500ECA43Q38233232-22596FDB-6E28-499D-8A2C-873E81DFC00FQ38308870-C91C9ECB-1B5F-4303-B5DF-8F809598C32BQ39306165-C138B177-5F0A-424F-95F8-9E5385F59CBCQ39327644-F2420354-0490-4694-8421-4074795E0407Q39593763-C80EDEA2-A50B-49A9-857A-71BF3EA2A5B4Q39642528-FD907604-C09D-4331-AA18-E57DC1C9F751Q39882481-82E2885C-ADBE-40C8-AA1A-C8852769A9E3Q40132033-AB8AC5C8-31CA-49C4-87FC-10FB35247BBBQ40335931-97842892-B5AF-4C83-96C9-1CE045AB419AQ40463686-F6698B9A-4FE4-4D57-B08E-73D18607C4BFQ41337979-683554F2-BAF6-49EA-8AA3-9A0F29081A82Q41572340-72507C60-609D-469B-8C0F-F635ED662C2DQ41962853-796E43C6-4F8F-4CC7-BC15-871E48C29F10Q42006546-0F1D0C42-5965-4919-8D6E-CA4A1667BE7EQ42424876-7D9CE0EF-DA0D-486D-87C8-883602E48134Q42723089-87ADBC25-B46E-40CF-992D-9CF401C63AFCQ42797291-4C12C697-9FE7-4C6C-886A-AEC9511B5845
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Release of canine parvovirus from endocytic vesicles.
@en
Release of canine parvovirus from endocytic vesicles.
@nl
type
label
Release of canine parvovirus from endocytic vesicles.
@en
Release of canine parvovirus from endocytic vesicles.
@nl
prefLabel
Release of canine parvovirus from endocytic vesicles.
@en
Release of canine parvovirus from endocytic vesicles.
@nl
P2093
P1433
P1476
Release of canine parvovirus from endocytic vesicles.
@en
P2093
Anne Jaatinen
Matti Vuento
Mia Antila
Sanna Suikkanen
P304
P356
10.1016/J.VIROL.2003.08.031
P407
P577
2003-11-01T00:00:00Z